Eli Lilly and Company (LLY)

332.95 0.35%
10:58 am EDT; Powered by Koyfin
Pros
Revenue growth higher than the industry and sector averages
Buy analyst rating
Cons
Company’s profitability is declining
Forward P/E ratio high relative to industry peers
Forward P/B ratio high relative to industry peers
Forward P/S ratio high relative to industry peers
Forward PEG ratio high relative to industry peers

Pros

  1. LLY quarterly revenue growth was 14.80%, higher than the industry and sector average revenue growth (11.37% and 6.06%, respectively). See LLY revenue growth chart.
  2. LLY average analyst rating is Buy. See LLY analyst rating chart.

Cons

  1. LLY profitability is declining. The YoY profit margin change was -13.79 percentage points. See LLY profitability chart.
  2. LLY forward P/E ratio is 37.34, which is high compared to its industry peers’ P/E ratios. See LLY forward P/E ratio chart.
  3. LLY Price/Book ratio is 42.61, which is high compared to its industry peers’ P/B ratios. See LLY forward Price/Book ratio chart.
  4. LLY Price/Sales ratio is 10.55, which is high compared to its industry peers’ P/S ratios. See LLY forward Price/Sales ratio chart.
  5. LLY PEG ratio (P/E adjusted for growth) is 3.74, which is high compared to its industry peers’ PEG ratios. See LLY PEG chart.